Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel Na+/H+ exchange inhibitor presented at Japanese congress

Sep. 27, 1999

PST-2107, an Na+/K+-ATPase inhibitor with significant advantages over digoxin

Sep. 27, 1999

Dual NEP/ACE inhibitor attenuates left ventricular remodeling without affecting blood pressure

Sep. 27, 1999

SmithKline Beecham scientists identify urotensin-II receptor

Sep. 27, 1999

Patient enrollment complete in first of United Therapeutics' pulmonary hypertension trials

Sep. 24, 1999

rhIL-10 improves survival and attenuates myocardial damage in experimental viral myocarditis

Sep. 24, 1999

Complement inhibitor TP-10 enters infant trial for cardiopulmonary bypass

Sep. 24, 1999

Potentially beneficial cardiovascular effects of raloxifene uncovered

Sep. 23, 1999

FDA gives Vasogen go-ahead for TAA trial

Sep. 23, 1999

Cypros receives fast track status for Cordox in CABG surgery

Sep. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026